Home / Drug shortages / Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/22/2012.

Shortage Details

Status
Current
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-3181-01
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)
Initial Posting
02/22/2012
Revised Date

FDA data resources